[
  {
    "ts": null,
    "headline": "Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know",
    "summary": "A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are \"likely to move us further away from our goals,\" referring to the Fed's dual mandate of price stability and maximum employment.",
    "url": "https://finnhub.io/api/news?id=c9b43e1c5e93b43a3e516319e88b34f060565c773c81b0f72c8db71bc8829908",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744833951,
      "headline": "Bloom Energy, Rogers, 3D Systems, Moderna, and EchoStar Stocks Trade Down, What You Need To Know",
      "id": 133942978,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "A number of stocks fell in the afternoon session after Federal Reserve Chair Jerome Powell signaled a cautious stance on future monetary policy decisions during a speech in Chicago, emphasizing that trade tariffs could add upward pressure to inflation in the short term and complicate the Fed's efforts to stabilize the economy. He warned that such trade measures are \"likely to move us further away from our goals,\" referring to the Fed's dual mandate of price stability and maximum employment.",
      "url": "https://finnhub.io/api/news?id=c9b43e1c5e93b43a3e516319e88b34f060565c773c81b0f72c8db71bc8829908"
    }
  },
  {
    "ts": null,
    "headline": "Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks",
    "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie (NYSE:ABBV).",
    "url": "https://finnhub.io/api/news?id=026dabbb2a99de471029a5b9ad880404d285a1fb63b67599c647a2c657d23bbe",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1744794365,
      "headline": "Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks",
      "id": 133935639,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie (NYSE:ABBV).",
      "url": "https://finnhub.io/api/news?id=026dabbb2a99de471029a5b9ad880404d285a1fb63b67599c647a2c657d23bbe"
    }
  }
]